KATHY FORD: Open Payments
NPI 1285633305 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 17 payments from 15 companies in 2025. Trend: 2023 $1,230 · 2024 $1,930 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $155 |
| PFIZER INC. | 1 | $125 |
| Daiichi Sankyo Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| BeOne Medicines USA, Inc. | 1 | $114 |
| Ipsen Biopharmaceuticals, Inc | 1 | $84 |
| PharmaEssentia USA Corporation | 1 | $66 |
| Tempus AI, Inc | 1 | $56 |
| ABBVIE INC. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
Products named: RYBREVANT, ADCETRIS, Enhertu, DATROWAY, BRUKINSA, Onivyde, BESREMI, XT CDX.
Industry payments across TX — which companies pay providers there.
